Table 1.
Distribution of BzRA Use (n = 193).
| Agenta | Trade name | Minimal therapeutic dose | Prevalence n (%) |
|---|---|---|---|
| Zolpidem | Ambien | 5 mg | 138 (71.5) |
| Temazepam | Restoril | 15 mg | 22 (11.4) |
| Eszopiclone | Lunesta | 2 mg | 13 (6.7) |
| Zolpidem ext. release | Ambien CR | 6.25 mg | 12 (6.2) |
| Zolpidem oral spray | Zolpimist | 5 mg | 2 (1.0) |
| Zolpidem sublingual | Intermezzo | 1.75 mg | 2 (1.0) |
| Flurazepam | Dalmane | 15 mg | 1 (0.5) |
| Triazolam | Halcion | 0.125 mg | 2 (1.0) |
| Zaleplon | Sonata | 10 mg | 1 (0.5) |
BzRA = benzodiazepine receptor agonist; mg = milligrams.
aThe following BzRAs were assessed, but not endorsed by any participants: Doral (Quazepam); Edluar (Sublingual Zolpidem); Prosom (Estazolam).